Physician profile
David S Moore
NPI 1861412967
$638.53
in general payments reported to CMS, 2019-2025
17 companies · $54.69 in 2025
The $54.69 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.76 · 2020: $50.30 · 2021: $165 · 2022: $81.78 · 2023: $107 · 2024: $86.05 · 2025: $54.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $247.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $206.58 | 2019-2025 | Bridion, Dificid |
| Chiesi USA, INC. | $71.28 | 2020-2022 | |
| Mallinckrodt Enterprises LLC | $68.21 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $54.95 | 2021-2025 | Entyvio |
| Mallinckrodt Hospital Products INC. | $40.60 | 2020-2021 | |
| Axonics, INC. | $25.47 | 2021 | |
| Janssen Biotech, INC. | $19.74 | 2024 | Tremfya |
| Acacia Pharma INC | $19.09 | 2022 | |
| Madrigal Pharmaceuticals | $16.76 | 2024 | Resmetirom |
| Ardelyx, INC. | $16.44 | 2023 | Ibsrela |
| Vertex Pharmaceuticals Incorporated | $16.36 | 2025 | |
| Teleflex LLC | $15.91 | 2024 | Urolift |
| Eagle Pharmaceuticals, INC. | $15.83 | 2023 | |
| Redhill Biopharma INC. | $13.86 | 2021 | |
| Abbvie INC. | $13.36 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $13.19 | 2022 | |
| Shire North American Group INC | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.